| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigation |
Department of Radiology, The Catholic University of Korea, Seoul, Korea
Correspondence: For correspondence or reprints contact: Ie Ryung Yoo, MD, Department of Radiology, Kangnam St. Mary's Hospital, Seocho-gu, Banpo-dong 505, Seoul, Korea 137-701. E-mail: iryoo{at}catholic.ac.kr
Small pulmonary nodules with little or no perceptible 18F-FDG uptake are relatively common findings on combined PET/CT images of patients with nonthoracic malignancies. Interpreting such nodules is often a diagnostic challenge, and this study aimed to evaluate the clinical significance of the nodules. Methods: Patients with pulmonary nodules 
1 cm in diameter showing no 18F-FDG uptake or uptake less than the mediastinal background were included. Nodules with clearly benign or metastatic findings on CT were excluded. One hundred twenty-one patients had either tissue confirmation or clinical follow-up with additional chest images. The subjects were studied by 3 variables: (i) solitary versus multiple nodules, (ii) presence of accompanying benign lung lesion versus absence, and (iii) imperceptible 18F-FDG uptake versus faint 18F-FDG uptake. The malignancy rates were calculated for each variable. Results: Of the 121 patients, 24 had malignancy, with a strong possibility of pulmonary metastasis (19.8%). Six of the 44 patients with solitary nodules (13.6%) and 18 of the 77 patients with multiple nodules (23.4%) had malignancies, though there was no statistically significant difference in the incidences of malignancy between the solitary and multiple groups. On the other hand, there was a statistically significant difference (P = 0.040) between the accompanying lung lesion present (8.3%) and absent (24.7%) groups. No statistically significant difference was noted between the 18F-FDG uptake imperceptible group and faint 18F-FDG uptake group (20.7% vs. 17.2%). Conclusion: For patients with incidental lung nodules of indeterminate nature with no 18F-FDG uptake or uptake less than that of the mediastinum on PET/CT images, >19% of the cases turned out to be malignant. The nodule was more likely to be malignant when no other benign pulmonary lesions could be identified elsewhere in the lung field. Thus, regardless of the number of nodules and 18F-FDG uptake, tissue confirmation or close imaging follow-up is necessary when small nodules with imperceptible or faint 18F-FDG activity are present on the PET/CT images, especially in the absence of accompanying benign lung lesions.
Key Words: 18F-FDG • PET/CT • pulmonary nodule • lung metastasis
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
|
|
 |
|
  C. A Yi, K. M. Shin, K. S. Lee, B.-T. Kim, H. Kim, O J. Kwon, J. Y. Choi, and M. J. Chung Non-Small Cell Lung Cancer Staging: Efficacy Comparison of Integrated PET/CT versus 3.0-T Whole-Body MR Imaging Radiology, August 1, 2008; 248(2): 632 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tian, X. Yang, L. Yu, P. Chen, J. Xin, L. Ma, H. Feng, Y. Tan, Z. Zhao, and W. Wu A Multicenter Clinical Trial on the Diagnostic Value of Dual-Tracer PET/CT in Pulmonary Lesions Using 3'-Deoxy-3'-18F-Fluorothymidine and 18F-FDG J. Nucl. Med., February 1, 2008; 49(2): 186 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Giaccone 18Fluorodeoxyglucose Positron Emission Tomography, a Standard Diagnostic Tool in Lung Cancer J Natl Cancer Inst, December 5, 2007; 99(23): 1741 - 1743. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
